In my career as a psychotherapist, I have seen more people complaining about not being able to fall asleep than about any other psychological issue. While any psychological distress may cause sleep difficulties, difficulty in falling asleep alone does not mean someone is suffering from a psychological or psychiatric illness. A variety of reasons can cause insomnia, and sometimes there is no reason at all. I do not want to get deep into the neurochemical and cognitive aspects of not being able to fall asleep. But, it suffices to say that stress, psychological or psychiatric disturbance, physical health, and sleep hygiene all play an important role in a person’s ability to fall asleep or an inability to do the same.
Popping sleeping tablets is often glamorized and glorified, but it has never been a panacea. In fact, tablets that assist in putting people to sleep usually have several side effects and should not be taken for years, even though most admit that they have been using them for decades. Doctors are often left with no choice but to prescribe anti-anxiety tablets or certain antidepressants in order to help people sleep better.
With that in mind, I was pleased to learn that Merck’s (MRK) insomnia drug has showed positive results. Suvorexant, the investigational insomnia medicine was studied over a period of 12 months and the results have been very satisfactory. The study was also one of the longest and continuously dosed trials that a sleep medication has ever received. To continue reading, click here.